𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dementia in Parkinson's disease challenges the “gold standard”

✍ Scribed by Gilberto Levy

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
48 KB
Volume
58
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endogenous dopamine release after pharma
Endogenous dopamine release after pharmacological challenges in Parkinson's disease
✍ Paola Piccini; Nicola Pavese; David J. Brooks 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

## Abstract Using ^11^C‐raclopride positron emission tomography after methamphetamine challenge, we have evaluated regional brain changes in synaptic dopamine (DA) levels in six volunteers and six advanced Parkinson's disease (PD) patients. The pharmacological challenge induced significant release

Alpha-synuclein promoter haplotypes and
Alpha-synuclein promoter haplotypes and dementia in Parkinson's Disease
✍ E.V. De Marco; P. Tarantino; F.E. Rocca; G. Provenzano; D. Civitelli; V. De Luca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## Abstract Dementia is a common complication of Parkinson's disease (PD). It correlates significantly with the presence of cortical, limbic or nigral Lewy bodies, mainly constituted of alpha‐synuclein. Mutations of the alpha‐synuclein gene (SNCA) have been linked to rare familial forms of PD, whil